Subject with histologically confirmed tumor or neuroendocrine carcinoma of the pancreas
Subject with tumors or neuroendocrine carcinoma of the pancreas regardless of the stage of the disease
Supported at the University Hospitals of Strasbourg between 01/01/2008 and 01/09/2019
Near therapeutic blood count available (less than 6 months)
Availability of frozen and/or paraffin tumor material
Patients who have already given their consent for their biological resources to be kept at the CRB or in the anatomopathology department of the HUS, and subsequently reused, as well as the anonymous data associated with them, for scientific research purposes.
Impossibility of giving informed information to the subject
Patient under judicial protection En savoir plus sur ce texte sourceVous devez indiquer le texte source pour obtenir des informations supplémentaires Envoyer des commentaires Panneaux latéraux
You may not be if
Opposition of the patient to participate in the study
Diagnosis other than pancreatic neuroendocrine tumor
Clareo Health | Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
